Relationship between methamphetamine-induced dopamine release, hyperthermia, self-injurious behaviour and long term dopamine depletion in BALB/c and C57BL/6 mice

Pharmacology and Toxicology

Volumn 93, Issue 1, 2003, Pages 33-41

  Halladay, Alycia K ^a   Kusnecov, Alexander ^a   Michna, Lauri ^a   Kita, Taizo ^b   Hara, Chiaki ^b   Wagner, George C ^a  

^a RUTGERS UNIVERSITY   (United States)

^b DAIICHI UNIVERSITY OF PHARMACY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; HOMOVANILLIC ACID; INTERLEUKIN 1BETA; METHAMPHETAMINE; PARACETAMOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOMUTILATION; BODY TEMPERATURE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DRUG ABUSE; FRONTAL CORTEX; HYPERTHERMIA; IMMUNE RESPONSE; MOUSE; NEUROTOXICITY; NONHUMAN; PREDICTION; PRIORITY JOURNAL; STRAIN DIFFERENCE; STRAIN IDENTIFICATION; STRIATE CORTEX; TOXICITY TESTING;

ACTINS; ANIMALS; BEHAVIOR, ANIMAL; CEREBRAL CORTEX; CORPUS STRIATUM; DOPAMINE; FEVER; INJECTIONS, SUBCUTANEOUS; INTERLEUKIN-1; METHAMPHETAMINE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SELF-INJURIOUS BEHAVIOR; SPECIES SPECIFICITY;

ANIMALIA;

EID: 0037669367     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2003.930105.x     Document Type: Article

References (31)

1. Albers, D. S. & P. K. Sonsalla: Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacologic profile of protective and nonprotective agents. J. Pharmacol. Exp. Therap. 1995, 275, 1104-1114.
2. Ali, S. F., G. D. Newport, R. R. Holson, W. Slikker & J. F. Bowyer: Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice. Brain Res. 1994, 658, 33-38.
3. Bowyer, J. F., D. L. Davies, L. Schmued, H. W. Broening, G. D. Newport, W Slikker & R. R. Holson: Further studies of the role of hyperthermia in methamphetamine toxicity. J. Pharm. Exp. Therap. 1994, 268, 1571-1580.
4. Bowyer, J. F., B. Gough, W. Slikker, G. W. Lipe, G. D. Newport & R. R. Holson: Effects of a cold environment or age on methamphetamine-induced dopamine release in the caudate putamen of female rats. Pharmacol. Biochem. Behav. 1993, 44, 87-98.
5. Brebner, K., S. Hayley, R. Zacharko, Z. Merali & H. Anisman: Synergistic effects of interleukin-1β, interleukin-6, and tumor necrosis factor-α: central monoamine, corticosterone, and behavioral variations. Neuropsychopharmacology 2000, 22, 566-580.
6. Breese, G. R., A. A. Baumeister, T. J. McCown, S. G. Everick, G. D Frye, K. Crotty & R. A. Mueller: Behavioral differences between neontal and adult 6-hydroxydopamine-treated rats to dopamine agonists: Relevance to neurological symptoms in clinical syndromes with reduced brain dopamine. J. Pharmacol. Exp. Therap. 1984, 231, 343-354.
7. Grundy, R. I., R. Rothwell & S. M. Allan: Dissociation between the effects of interleukin-1 on excitotoxic brain damage and body temperature in the rat. Brain Res. 1999, 830, 32-37.
8. Halladay, A. K, H. Fisher & G. C. Wagner: Interaction of phentermine and fenfluramine: Neurochemical and neurotoxic effects. Neurotoxicology 1998, 19, 177-183.
9. Itzhak, Y., J. L. Martin & S. F. Ali: nNOS inhibitors attenuate methamphetamine-induced dopaminergic neurotoxicity but not hyperthermia in mice. Neuroreport 2000, 11, 2943-2946.
10. Kelley, A. E., A. M. Gauthier & C. G. Lang: Amphetamine microinjections into distinct striatal subregions cause dissociable effects on motor and ingestive behavior. Behav. Brain Res. 1989, 35, 27-39.
11. Kelly, P. H., P. W. Seviour & S. D. Iversen: Amphetamine and ampomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res. 1975, 94, 507-522.
12. Kita, T., Y. Matsunari, T. Saraya, K. Shimada, K. O'Hara, K. Kubo, G. C. Wagner & T. Nakashima: Methamphetamine-induced striatal dopamine release, behavior changes and neurotoxicity in BALB/c mice. Int. J. Dev. Neurosci. 2000, 18, 521-530.
13. Kita, T., S. Paku, M. Takahashi, K. Kubo, G. C. Wagner & T. Nakashima: Methamphetamine-induced neurotoxicity in BALB/c, DBA/2N and C57BL/6N mice. Neuropharmacology 1998, 37, 1177-1184.
14. Lacosta, S., Z. Merali & H. Anisman: Influence of interleukin-1β on exploratory behaviors, plasma ACTH, corticosterone, and central biogenic amines in mice. Psychopharmaocology 1998, 137, 351-361.
15. Ladenheim, B., I. N. Krasnova, X. Deng, J. M. Oyler, A. Polettini, T. H. Moran, M. A. Huestis & J. L. Cadet: Methamphetamine-induced neurotoxicity is attenuated in transgenic mice with a null mutation for interleukin-6. Mol. Pharmacol. 2000, 58, 1247-1256.
16. 11C] WIIN-35,428. J. Neurosci. 1998, 18, 8417-8422.
17. Melega, W. P, G. Lacan, D. C. Harvey, S.-C. Huang & M. E. Phelps: Dizocilpine and reduced body temperature do not prevent methamphetamine-induced neurotoxicity in the vervet monkey: WIN 35,428 B positron emission tomography studies. Neurosc. Letters 1998, 258, 17-20.
18. Melega, W. P., G. Lacan, D. B. Stout, S.-C. Huang & M. E. Phelps: Recovery of striatal dopamine function after acute amphetamine and methamphetamine-induced neurotoxicity in the vervet monkey. Brain Res. 1997, 766, 113-120.
19. Metzger, R. R., H. M. Haughey, D. G. Wilkins, J. W Gibb, G. R. Hanson & A. E. Fleckenstein: Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia. J. Pharmacol. Exp. Therap. 2000, 295, 1077-2085.
20. MohanKumar, S. M. J., P. S. MohanKumar & S. K. Quadri: Specificity of interleukin-1β-induced changes in monoamine concentrations in hypothalamic nuclei: Blockade by interleukin-1 receptor antagonst. Brain Res. Bull. 1998, 47, 29-34.
21. O'Callaghan, J. P. & D. B. Miller: Neurotoxicity profiles of substituted amphetamine in the C57BL/6J mouse. J. Pharmacol. Exp. Therap. 1994, 270, 741-751.
22. Seiden, L. S., M. W. Fischman & C. R. Schuster: Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys. Drug & Alcohol Dependence 1976, 1, 215-219.
23. Tringali, G., A. Mirtella, C. Mancuso, G. Guerriero, P. Preziosi & P. Navarra: The release of immunoreactive interleukin-1β from rat hypothalamic explants is modulated by neurotransmitters and corticotropin-releasing hormaone. Pharmacol. Res. 1997 36, 269-273.
24. Wagner, G. C., G. A. Ricuarte, L. S. Seiden, C. R. Schuster, R. J. Miller & J. Westley: Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res. 1980, 181, 151-160.
25. Wagner, G. C., J. B. Lucot, C. R. Schuster & L. S. Seiden: Alpha-methyltyrosine attenuates and reserpine increases methamphetamine-induced neuronal changes. Brain Res. 1983, 270, 285-288.
26. Wallace, T. L., G. A. Gudelsky & C. V. Vorhees: Neurotoxic regimen of methamphetamine produces evidence of behavioral sensitization in the rat. Synapse 2001, 39, 1-7.
27. Wilson, J. M, K. S. Kalasinsky, A. I. Levey, C. Bergeron, G. Reiber, R. M. Anthony, G. A. Schmunk, K. Shannak, J. W. Haycock & S. J. Kish: Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nature Medicine 1996, 2, 699-703.
28. Woolverton, W. L., G. A. Ricaurte, L. S. Forno & L. S. Selden: Long term effects of chronic methamphetamine in rhesus monkeys. Brain Res. 1989, 486, 73-78.
29. Xie, T., U. D. McCann, S. Kim, J. Yuan & G. A. Ricaurte: Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: Implications for methamphetamine-induced dopaminergic neurotoxicity. J. Neurosci. 2000, 20, 7838-7845.
30. Yamaguchi, T., Y. Kuraishi, K. Yabuuchi, M. Minami & M. Satoh: In situ hybridization analysis of the induction of Interleukin-1β mRNA by methamphetamine in the rat hypothalamus. Mol. Cell. Neurosci. 1991, 2, 259-265.
31. Yuan, J., B. T. Callahan, U. D. McCann & G.A. Ricaurte: Evidence against an essential role of endogenous brain dopamine in methamphetamine-induced dopaminergic neurotoxicity. J. Neurochem. 2001, 77, 1338-1347.